RxTROSPECT Oncology is a regulatory precedent identification tool that provides cloud-based analytics on US and EU oncology approvals (original approvals and follow-on indications). Identify and export precedent on indication, study design, pivotal study phase and size, regulatory pathways, key efficacy and safety data and so much more. Reach out to us at theteam@rxtrospect.com to understand how our clients are saving a tremendous amounts of time in precedent identification to expedite the development of regulatory strategy.